Agape ATP Corp (ATPC) stock

ATPCNasdaqServices-Health ServicesFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 8/30

$1.27−0.09 (-6.62%)

Close on Nov 13, 2026Market cap $1.27MP/E –Yield –

Agape ATP price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Agape ATP's price to sales ratio was 1.2× on Nov 11, 2026, against 43.4× a year earlier. Over the last 5 years it ranged from 1.2× to 403.1×, with a median of 33.5×.

Price to Sales Ratio at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	1.2×	−2.4
2025	Dec 31, 2025	3.6×	+0.1
2024	Dec 31, 2024	3.5×	−30.3
2023	Dec 29, 2023	33.8×	−146.3
2022	Dec 30, 2022	180.1×	–

Where these numbers come from

Parsed from the XBRL in Agape ATP's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-50 reverse split on Feb 10, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ATPC.

Compare: ATPC vs LDDD · ATPC vs EUDA · ATPC vs ALPS · ATPC vs DQWS · ATPC vs UMEW

Revenue growth-20.3% · median -55.5%

Gross margin55.9% · median 25.5%

Operating margin-271.4% · median -34.7%

Net margin-100.2% · median -31.8%

Company	Revenue	Growth
DQWS	$1.89M	-53.8%
LDDD	$1.82M	-57.2%
ATPC	$1.15M	-20.3%
UMEW	$1.04M	–
EUDA	–	–
ALPS	–	–

Company

Exchange: Nasdaq
Industry: Services-Health Services
Fiscal year ends: December 31
Employees: 18
Held by institutions: 10.5%
Auditor: Assentsure PAC
SEC CIK: 1713210

Advertisement
300 × 250

See a number that looks wrong?

Agape ATP price to sales ratio

Price to Sales Ratio at the end of each year

More Agape ATP figures